Dr Anchalee Avihingsanon Discusses Treatment as Prevention for HIV/HBV Coinfection - AJMC.com Managed Markets Network
8/7/2022 12:00:00 AM2 years 8 months ago
by Maggie L. Shaw
by Maggie L. Shaw
Anchalee Avihingsanon, MD, PhD, HIV-NAT, Thai Red Cross AIDS Research Centre, Bangkok, Thailand, is principal investigator of the ALLIANCE trial from Gilead.
The ALLIANCE trial from Gilead is investigating the triplet regimen of bictegravir/emtricitabine/tenofovir alafenamide (TAF) vs dolutegravir plus emtricitabine/tenofovir disoproxil fumarate (TDF) amo… [+1560 chars]
full article...